Spots Global Cancer Trial Database for liposomal pegylated doxorubicine
Every month we try and update this database with for liposomal pegylated doxorubicine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years | NCT00563953 | Breast Cancer | Liposomal pegyl... | 18 Years - | SOLTI Breast Cancer Research Group |